Cite
HARVARD Citation
Walter, R. et al. (n.d.). Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia. American journal of hematology. 93 (2), pp. E49-E52. [Online].